Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1954 May;30(5):343–375.

Polycythemia Vera–Its Course and Treatment: Relation to Myeloid Metaplasia and Leukemia*

Louis R Wasserman
PMCID: PMC1804490  PMID: 13150002

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACK-SCHAFFER B., STODDARD L. D. Panmyelosis and chronic granulocytic leukemia. Am J Pathol. 1953 May-Jun;29(3):413–449. [PMC free article] [PubMed] [Google Scholar]
  2. BLOCK M., JACOBSON L. O. Myeloid metaplasia. J Am Med Assoc. 1950 Aug 19;143(16):1390–1396. doi: 10.1001/jama.1950.02910510008002. [DOI] [PubMed] [Google Scholar]
  3. DAMESHEK W. Physiopathology and course of polycythemia vera as related to therapy. J Am Med Assoc. 1950 Mar 18;142(11):790–797. doi: 10.1001/jama.1950.02910290018005. [DOI] [PubMed] [Google Scholar]
  4. DAMESHEK W. Some speculations on the myeloproliferative syndromes. Blood. 1951 Apr;6(4):372–375. [PubMed] [Google Scholar]
  5. GRANT W. C., ROOT W. S. Fundamental stimulus for erythropoiesis. Physiol Rev. 1952 Oct;32(4):449–498. doi: 10.1152/physrev.1952.32.4.449. [DOI] [PubMed] [Google Scholar]
  6. HICKLING R. A. Gout, leukaemia, and polycythaemia. Lancet. 1953 Jan 10;1(6750):57–59. doi: 10.1016/s0140-6736(53)91545-1. [DOI] [PubMed] [Google Scholar]
  7. HUFF R. L., HENNESSY T. G., AUSTIN R. E., GARCIA J. F., ROBERTS B. M., LAWRENCE J. H. Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders. J Clin Invest. 1950 Aug;29(8):1041–1052. doi: 10.1172/JCI102335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HUTT M. S. R., PINNIGER J. L., WETHERLEY-MEIN G. The myeloproliferative disorders with special reference to myelofibrosis. Blood. 1953 Apr;8(4):295–314. [PubMed] [Google Scholar]
  9. KARNOFSKY D. A., BURCHENAL J. H., ARMISTEAD G. C., Jr, SOUTHAM C. M., BERNSTEIN J. L., CRAVER L. F., RHOADS C. P. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. AMA Arch Intern Med. 1951 Apr;87(4):477–516. doi: 10.1001/archinte.1951.03810040002001. [DOI] [PubMed] [Google Scholar]
  10. LAWRENCE J. H., BERLIN N. I., HUFF R. L. The nature and treatment of polycythemia; studies on 263 patients. Medicine (Baltimore) 1953 Sep;32(3):323–388. doi: 10.1097/00005792-195309000-00002. [DOI] [PubMed] [Google Scholar]
  11. ROSENTHAL M. C. Extramedullary hemapoiesis; myeloid metaplasia. Bull New Engl Med Cent. 1950 Aug;12(4):154–160. [PubMed] [Google Scholar]
  12. ROSENTHAL N., ROSENTHAL R. L. Treatment of polycythemia vera with triethylene melamine; summary of thirty cases. AMA Arch Intern Med. 1952 Sep;90(3):379–388. doi: 10.1001/archinte.1952.00240090100008. [DOI] [PubMed] [Google Scholar]
  13. SCHWARTZ S. O., EHRLICH L. The relationship of polycythemia vera to leukemia; a critical review. Acta Haematol. 1950 Sep;4(3):129–147. doi: 10.1159/000203745. [DOI] [PubMed] [Google Scholar]
  14. STATS D. The sedimentation differential agglutination test. I. Method of the test. II. Observations on the destruction and production of red cells, with special reference to myeloblastic leukemia and comparison with the results of the radioactive phosphorus method. Blood. 1950 Oct;5(10):950–963. [PubMed] [Google Scholar]
  15. STROEBEL C. F., HALL B. E., PEASE G. L. Evaluation of radiophosphorus therapy in primary polycythemia. J Am Med Assoc. 1951 Aug 4;146(14):1301–1307. doi: 10.1001/jama.1951.03670140027008. [DOI] [PubMed] [Google Scholar]
  16. Schafer P. W. The Etiology and Treatment of Polycythemia Rubra Vera : Observations Based upon Studies of Body Fluid Changes in Dogs Subjected to Proprioceptor Depressor Neurotomy and Extensive Sympathectomy, Including the Case Report of a Man with Polycythemia Rubra Vera Treated by Extensive Para-Vertebral Sympathectomy. Ann Surg. 1945 Dec;122(6):1098–1124. [PMC free article] [PubMed] [Google Scholar]
  17. Schwartz B. M., Stats D. OXYGEN SATURATION OF STERNAL MARROW BLOOD IN POLYCYTHEMIA VERA. J Clin Invest. 1949 Jul;28(4):736–740. doi: 10.1172/JCI102125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. VIDEBAEK A. Polycythaemia vera. Course and prognosis. Acta Med Scand. 1950;138(3):179–187. doi: 10.1111/j.0954-6820.1950.tb10111.x. [DOI] [PubMed] [Google Scholar]
  19. WASSERMAN L. R., RASHKOFF I. A., LEAVITT D., MAYER J., PORT S. The rate of removal of radioactive iron from the plasma; an index of erythropoiesis. J Clin Invest. 1952 Jan;31(1):32–39. doi: 10.1172/JCI102574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. WASSERMAN L. R., RASHKOFF I. A. The use of radioactive and stable isotopes in hematology. J Mt Sinai Hosp N Y. 1951 Mar-Apr;17(6):1037–1047. [PubMed] [Google Scholar]
  21. WISEMAN B. K., ROHN R. J., BOURONCLE B. A., MYERS W. G. The treatment of polycythemia vera with radioactive phosphorus. Ann Intern Med. 1951 Feb;34(2):311–330. doi: 10.7326/0003-4819-34-2-311. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES